Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
Open | $0.920 |
Close | $0.940 |
Volume / Avg. | 205.541K / 679.921K |
Day Range | 0.900 - 0.970 |
52 Wk Range | 0.740 - 1.760 |
Market Cap | $38.591M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 0.15% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achilles Therapeutics (NASDAQ: ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Achilles Therapeutics (NASDAQ: ACHL) was reported by Piper Sandler on Friday, April 5, 2024. The analyst firm set a price target for 2.00 expecting ACHL to rise to within 12 months (a possible 115.05% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.93 last updated May 10, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.